Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Adamichou

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Lupus|December 4, 2021
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sampleEmmanouil Papastefanakis, Georgia Dimitraki, Georgia Ktistaki, et al.
Cureus|August 5, 2025
Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis Presenting With Disseminated Streptococcus constellatus Pyogenic InfectionErieta Karypidou, Christos Mademlis, Christina Adamichou, et al.
Clinical and Experimental Rheumatology|October 17, 2025
Cardiac strain in patients on Janus Kinase inhibitors for rheumatic diseases: a 1-year echocardiographic studyNikolaos Kougkas, Elpida Skouvaklidou, Konstantinos Tsafis, et al.
Annals of the Rheumatic Diseases|August 7, 2017
Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, GreeceIrini Gergianaki, Antonis Fanouriakis, Argyro Repa, et al.
Rheumatology (Oxford, England)|June 30, 2020
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control studyStylianos Panopoulos, Konstantinos Thomas, Georgios Georgiopoulos, et al.
Seminars in Arthritis and Rheumatism|April 2, 2020
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational studySule Yavuz, Dondu U Cansu, Dionysis Nikolopoulos, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatmentSofia Papanikolaou, Evgenia Emmanouilidou, Christina Adamichou, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Lupus|December 4, 2021
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sampleEmmanouil Papastefanakis, Georgia Dimitraki, Georgia Ktistaki, et al.
Cureus|August 5, 2025
Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis Presenting With Disseminated Streptococcus constellatus Pyogenic InfectionErieta Karypidou, Christos Mademlis, Christina Adamichou, et al.
Clinical and Experimental Rheumatology|October 17, 2025
Cardiac strain in patients on Janus Kinase inhibitors for rheumatic diseases: a 1-year echocardiographic studyNikolaos Kougkas, Elpida Skouvaklidou, Konstantinos Tsafis, et al.
Annals of the Rheumatic Diseases|August 7, 2017
Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, GreeceIrini Gergianaki, Antonis Fanouriakis, Argyro Repa, et al.
Rheumatology (Oxford, England)|June 30, 2020
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control studyStylianos Panopoulos, Konstantinos Thomas, Georgios Georgiopoulos, et al.
Seminars in Arthritis and Rheumatism|April 2, 2020
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational studySule Yavuz, Dondu U Cansu, Dionysis Nikolopoulos, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatmentSofia Papanikolaou, Evgenia Emmanouilidou, Christina Adamichou, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Pageof 3